Literature DB >> 29948613

Transforming Growth Factor Beta 2 Inhibits Growth and Proliferation Potential of Smad4 and p53 Mutated Human Colon Adenocarcinoma Cells.

Ramamoorthi Ganesan1, Nageswaran Sivalingam2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29948613     DOI： 10.1007/s12253-018-0423-7

Source DB:  PubMed          Journal:  Pathol Oncol Res        ISSN： 1219-4956            Impact factor:   3.201


× No keyword cloud information.
  16 in total

Review 1.  TGF-beta signalling in colon carcinogenesis.

Authors:  Pavlos Lampropoulos; Adamantia Zizi-Sermpetzoglou; Spyros Rizos; Alkiviadis Kostakis; Nikolaos Nikiteas; Athanasios G Papavassiliou
Journal:  Cancer Lett       Date:  2011-10-07       Impact factor: 8.679

2.  Role of TGF-beta1, its receptor TGFbetaRII, and Smad proteins in the progression of colorectal cancer.

Authors:  Maya Gulubova; Irena Manolova; Julian Ananiev; Alexander Julianov; Yovcho Yovchev; Katya Peeva
Journal:  Int J Colorectal Dis       Date:  2010-02-18       Impact factor: 2.571

Review 3.  TGFbeta in Cancer.

Authors:  Joan Massagué
Journal:  Cell       Date:  2008-07-25       Impact factor: 41.582

4.  Cancer statistics, 2016.

Authors:  Rebecca L Siegel; Kimberly D Miller; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2016-01-07       Impact factor: 508.702

5.  The potential role of TGFbeta1, TGFbeta2 and TGFbeta3 protein expression in colorectal carcinomas. Correlation with classic histopathologic factors and patient survival.

Authors:  Athanassios C Tsamandas; Dimitrios Kardamakis; Panagiota Ravazoula; Vassiliki Zolota; Stavroula Salakou; Konstantinos Tepetes; Cristina Kalogeropoulou; Irene Tsota; Theodore Kourelis; Thomas Makatsoris; Dionissios Karavias; Chrisoula D Scopa; Dionysis S Bonikos; Haralambos P Kalofonos; Theodore Petsas
Journal:  Strahlenther Onkol       Date:  2004-04       Impact factor: 3.621

Review 6.  Smad-dependent and Smad-independent pathways in TGF-beta family signalling.

Authors:  Rik Derynck; Ying E Zhang
Journal:  Nature       Date:  2003-10-09       Impact factor: 49.962

Review 7.  Molecular mechanism of TGF-β signaling pathway in colon carcinogenesis and status of curcumin as chemopreventive strategy.

Authors:  Ganesan Ramamoorthi; Nageswaran Sivalingam
Journal:  Tumour Biol       Date:  2014-03-26

Review 8.  Complexities of TGF-β targeted cancer therapy.

Authors:  Erin C Connolly; Julia Freimuth; Rosemary J Akhurst
Journal:  Int J Biol Sci       Date:  2012-07-12       Impact factor: 6.580

9.  Dexamethasone Inhibits TGF-β1-Induced Cell Migration by Regulating the ERK and AKT Pathways in Human Colon Cancer Cells Via CYR61.

Authors:  Sanghoon Han; Ngoc Thuy Bui; Manh Tin Ho; Young Mee Kim; Moonjae Cho; Dong Bok Shin
Journal:  Cancer Res Treat       Date:  2015-12-15       Impact factor: 4.679

10.  Loss of TGFβ signaling promotes colon cancer progression and tumor-associated inflammation.

Authors:  Daniel R Principe; Brian DeCant; Jonas Staudacher; Dominic Vitello; Riley J Mangan; Elizabeth A Wayne; Emman Mascariñas; Andrew M Diaz; Jessica Bauer; Ronald D McKinney; Khashayarsha Khazaie; Boris Pasche; David W Dawson; Hidayatullah G Munshi; Paul J Grippo; Barbara Jung
Journal:  Oncotarget       Date:  2017-01-17
View more
  2 in total

1.  Genetic Disruption of Guanylyl Cyclase/Natriuretic Peptide Receptor-A Triggers Differential Cardiac Fibrosis and Disorders in Male and Female Mutant Mice: Role of TGF-β1/SMAD Signaling Pathway.

Authors:  Umadevi Subramanian; Chandramohan Ramasamy; Samivel Ramachandran; Joshua M Oakes; Jason D Gardner; Kailash N Pandey
Journal:  Int J Mol Sci       Date:  2022-09-29       Impact factor: 6.208

2.  The Influence of Adalimumab and Cyclosporine A on the Expression Profile of the Genes Related to TGFβ Signaling Pathways in Keratinocyte Cells Treated with Lipopolysaccharide A.

Authors:  Iwona Adwent; Beniamin Oskar Grabarek; Marta Kojs-Mrożkiewicz; Ryszard Brus; Rafał Staszkiewicz; Andrzej Plewka; Michał Stasiowski; Anita Lyssek-Boroń
Journal:  Mediators Inflamm       Date:  2020-07-26       Impact factor: 4.711
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.